Description

Flamin Storage
active substance: 1 tablet contains flamine in terms of the content of the amount of flavonoids 70% 50 mg;

excipients: lactose monohydrate; potato starch; corn starch; magnesium carbonate light; calcium stearate.

Flamin Dosage form
Tablets.

Main physical and chemical properties: tablets of yellow or yellow with a brownish tinge, with specks, with a faint specific odor, flat-cylindrical shape, beveled.

Flamin Pharmacotherapeutic group
Means used in diseases of the liver and biliary tract. ATX code A05A X.

Pharmacological properties

Pharmacodynamics.

Flavonoid polyphenolic drug from inflorescences of sand cumin (immortelle). Contains flavonoid glycosides (salipurposide, isosalipurposide, kaempferol, apigenin), bitters, tannins, sterols, essential oils and other biologically active substances (organic acids, carotenoids, polysaccharides).

Increases bile secretion, changes the ratio of “cholesterol / bile acids”, increases the content of cholates in bile, prevents the formation of gallstones. Has an antispasmodic effect on the smooth muscles of the gallbladder sphincters and biliary tract. Stimulating the secretion of gastric juice, promotes better digestion. It has hypocholesterolemic and hepatoprotective effects. The drug reduces the inflammatory process in the liver parenchyma and biliary tract, facilitates blood circulation in the liver. The most important in the pharmacodynamics of the drug is its ability to stabilize cells and subcells of the liver membrane, which is based on its antioxidant effect.

Pharmacokinetics.

Not studied.

Indication
Chronic cholecystitis, chronic hepatitis, biliary dyskinesia.

Contraindication
Hypersensitivity to the components of the drug; obstructive jaundice, gallstone disease with stones larger than 10 mm in diameter, exacerbation of peptic ulcer disease, acute inflammatory diseases of the liver, gallbladder and biliary tract and pancreas.

Interaction with other medicinal products and other forms of interaction
The drug can be used in combination with other drugs that are prescribed for diseases of the liver and biliary tract.

The drug increases the activity of metronidazole and aminoquinol in the treatment of giardiasis.

If you need to take any other medicines at the same time, tell your doctor.

Features of application
Use with caution in patients with increased gastric acid-forming function.

The drug contains lactose. If a patient has an intolerance to certain sugars, consult a doctor before taking this medicine.

Use during pregnancy or breastfeeding.

Peculiarities of drug use during pregnancy or breastfeeding have not been studied. The use of the drug is possible if, in the opinion of the doctor, the expected benefit to the mother outweighs the potential risk to the fetus or child.

Ability to influence the speed of reaction when driving a car or other machinery.

Does not affect.